A Study to Evaluate the Efficacy and Safety of Vonoprazan Compared to Placebo for Relief of Heartburn in Participants With Symptomatic Non-Erosive Gastroesophageal Reflux Disease (NERD)

Clinical trial NCT05195528 · COMPLETED

Trial details

NCT number: NCT05195528
Sponsor: Phathom Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Non-Erosive Gastro-Esophageal Reflux Disease Heartburn

Start date: 2022-01-17
Primary completion: 2022-11-21
Enrollment: 776

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.